Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check2 days agoChange DetectedAccess to the study record is blocked, and the page now displays a 403 Forbidden message with a minimal header and a Home link. Previous study-related sections and metadata have been removed or hidden, replacing the detailed content with the error page.SummaryDifference18%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new Revision: v3.6.6 tag has been added to the page. The earlier Revision: v3.6.5 entry and several related topics (Lung cancer, related topics:, MedlinePlus Genetics) have been removed from the page.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded 2015 ( U.S. NIH Grant/Contract ) as a funding reference and included related topic tags Lung cancer and MedlinePlus Genetics to the study record. These changes serve as metadata to aid indexing and contextual understanding of the study.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page no longer displays the MedlinePlus related topics blocks for 'Lung Cancer' and 'MedlinePlus Genetics', including the related topics header. This alters only ancillary navigation elements and does not change the study data or enrollment information.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision shows v3.6.5 replacing v3.6.4, indicating a small update to the page's revision history rather than substantive content changes.SummaryDifference0.0%

- Check51 days agoChange DetectedThe related topics section now includes 'Lung cancer' and 'MedlinePlus Genetics', connecting the study to the disease category and providing quick access to genetics information.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.